ANGPT2 and Sjogren syndrome: Another study also stated that angiopoietin-2 may be used as a potential biomarker in SLE, since this marker seemed to have potential to differentiate patients with SLE from those with rheumatoid arthritis, osteoarthritis, gout, Sjögren’s syndrome and ankylosing spondylitis.48